CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Operating expenses:
Research and development	$ 3,931,600	$ 2,432,700
General and administrative	13,918,600	4,344,400
Total operating expenses	17,850,200	6,777,100
Loss from operations	(17,850,200)	(6,777,100)
Other expenses, net:
Interest expense, net	(770,800)	(4,548,700)
Change in warrant liability	(1,894,700)	(34,600)
Loss on extinguishment of debt	(26,700,200)	(2,388,000)
Other expense	(2,300)	(135,000)
Loss before income taxes	(47,218,200)	(13,883,400)
Income taxes	(2,300)	(2,400)
Net loss and comprehensive loss	(47,220,500)	$ (13,885,800)
Accrued dividends on Series B Preferred stock	(2,140,500)
Deemed dividend on Series B Preferred Units	(2,058,000)
Net loss attributable to common stockholders	$ (51,419,000)	$ (13,885,800)
Basic net loss attributable to common stockholders per common share (in dollars per share)	$ (29.08)	$ (10.53)
Diluted net loss attributable to common stockholders per common share (in dollars per share)	$ (29.08)	$ (10.61)
Weighted average shares used in computing:
Basic net loss attributable to common stockholders per common share (in shares)	1,767,957	1,318,813
Diluted net loss attributable to common stockholders per common share (in shares)	1,767,957	1,318,813